Altimmune (ALT) Non-Current Deferred Tax Liability (2017 - 2019)

Altimmune (ALT) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $58500.0 in Q2 2019.

• Quarterly Non-Current Deferred Tax Liability fell 98.68% year-over-year to $58500.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $58500.0 (down 98.68% YoY) and the FY2018 annual result came in at $58500.0, down 99.01% from the prior year.
• Non-Current Deferred Tax Liability was little changed at $58500.0 in Q2 2019 per ALT's latest filing, from $58500.0 in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $8.5 million in Q2 2017 and bottomed at $58500.0 in Q4 2018.
• The 3-year median for Non-Current Deferred Tax Liability is $4.4 million (2018), against an average of $4.0 million.
• Peak annual rise in Non-Current Deferred Tax Liability reached 48.14% in 2018, while the deepest fall reached 99.01% in 2018.
• Tracing ALT's Non-Current Deferred Tax Liability over 3 years: stood at $5.9 million in 2017, then sank by 99.01% to $58500.0 in 2018, then changed by 0.0% to $58500.0 in 2019.
• Per Business Quant, the three latest ALT Non-Current Deferred Tax Liability figures stand at $58500.0 (Q2 2019), $58500.0 (Q1 2019), and $58500.0 (Q4 2018).

Peer Comparison